Source: Pain News Network
A Canadian doctor is recruiting patients for a "first of its kind" stem cell research project for osteoarthritis. The Phase II study could further advance the use of regenerative medicine in treating osteoarthritis, a joint disease for which treatment options are currently limited to pain medication, steroid injections or joint replacement surgery.
In new research from the Wake Forest Institute for Regenerative Medicine (WFIRM), scientists have shown that bioengineered uteri supported fertilization, fetal development, and live birth with normal offspring.
According to the American Society of Gene & Cell Therapy, regenerative medicine may be defined as a branch of medicine that aims to repair damaged tissue. “Repair” may involve the replacement or regeneration of human cells, tissues, or organs.
Scientists at RCSI University of Medicine and Health Sciences have developed a new biomaterial that has the potential to accelerate bone regeneration by promoting an immune response that encourages repair and lowers the risk of inflammation.
Source: Mining Journal
Amniotic materials have many applications in medicine, especially sports medicine. The beneficial properties of amniotic fluid have it poised to become a major player in the healthcare market, especially with the trend-setter, Medicare, leading the way.
The thin, slippery layer of cartilage between the bones in the knee is magical stuff: strong enough to withstand a person's weight, but soft and supple enough to cushion the joint against impact, over decades of repeat use.
A break through feat of growing pluripotency expressing cells from osteoarthritis (OA) affected cartilage tissue of knee joints of elderly has been reported by orthopedicians and cell culture experts led by Dr Shojiro Katoh, President, Edogawa Hospital.